Clinical Trial Readout Diligence

Doing diligence on clinical trial readouts with our BPIQ team

Reminds me of some important considerations for the likelihood of success:

⇨Prior data for the on-test drug

⇨⇨Same endpoints?

⇨⇨Not available? Then prior trial data for other drugs with the same MOA

⇨Trial design

⇨⇨ Are the characteristics of patients allowed into the trial the same?

⇨⇨⇨ Especially the severity of the disease

⇨⇨How many patients?

⇨⇨How many clinical sites?

& Likelihood of stock move

⇨Market reaction to prior readout

See even more about clinical trial readouts and recent news by following our Twitter feed here: (https://twitter.com/BiopharmIQ)